Insmed Incorporated, a global biopharmaceutical company, closed a million strategic financing. The company has announced three strategic financings resulting in aggregate gross proceeds of USD 775 million. Proceeds from the transactions will strengthen Insmed’s financial position, which will place the Company in a position to deliver clinical data from each of its four pillars. The financing […]
Accelleron Industries and Turbo Systems Schweiz have entered into a CHF 450 m credit facilities agreement with Credit Suisse Switzerland as mandated lead arranger, agent and original lender. Based in Baden, Accelleron is a renowed company
BGPartner has advised Araris Biotech in a CHF 24 million financing round, involving the two co-lead investors 4BIO Capital and Pureos Bioventures. Araris Biotech, a company pioneering antibody-drug conjugate (ADC) linker technology, intends to use the
Walder Wyss has advised Swiss Life and Swiss Life Holding on its new CHF 500 million syndicated revolving credit facility with UBS Switzerland as agent, coordinator, mandated lead arranger and lender and Credit Suisse Switzerland, Deutsche
Niederer Kraft Frey has advised Gasverbund Mittelland on the raising of a EUR 200 million syndicated credit facility focused on securing the provision of gas during the upcoming heating season. The company is a renowed procurement
DPE Deutsche Private Equity, a renowed growth investor in the DACH region, has successful closed the named DPE Continuation Fund I with a fund size of EUR 708 million. The transaction represents the largest German GP-led
Walder Wyss has advised UBS Switzerland as mandated lead arranger, agent and security agent and the other syndicate banks on a CHF 150m syndicated credit facility for Auto-Interleasing. Auto-Interleasing is an owner-managed family business that
The listed company Basilea Pharmaceutica, a commercial-stage biopharmaceutical company, entered into a senior secured loan agreement with funds managed by the US company Athyrium Capital Management. The CHF 75 million senior secured loan will be used
Société Générale is providing the financing for the acquisition of 35 Vectron AC locomotives from Siemens Mobility. The locomotives will be acquired
VISCHER has advised Forty51 Ventures, a Biotech venture capital firm, on its first fund, Forty51 Ventures Fund I which has raised USD 43 million in a first closing and is domiciled in Luxemburg. VISCHER has supported,
